This supports using whole exome sequencing (WES) as an initial diagnostic tool for neurodevelopmental disorders (NDDs), surpassing targeted molecular studies like FMR1 triplet expansion or aCGH [12,13,14]. This evidence concerns the gene FMR1 and neurodevelopmental disorder.